Assure Holdings Announces the Establishment of a New Technologist Training and Education Program
20 October 2020 - 11:30PM
Assure Holdings Corp. (the “
Company” or
“
Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of
intraoperative neuromonitoring services (“
IONM”),
has announced a new education and training program for
technologists. To lead this effort, the Company has appointed
Ramesh Vijay to the newly created director of education position.
“Given the limited number of trained certified IONM
technologists, estimated at approximately 5,000 individuals
nationwide, building our own talent pipeline is essential to
prepare for our anticipated growth and maintaining exceptional
service,” said John A. Farlinger, Assure’s executive chairman and
CEO. “To alleviate the bottleneck for technologists and foster the
pipeline necessary for staffing our growth opportunities, Assure is
developing our own technologist training program. We will be one of
only a handful of IONM companies that are developing our own talent
in this manner.”
Vijay will oversee Assure’s training program. This will include
educating newly hired non board-certified technologists via
didactic courses, clinical training and board preparation as well
as the development of continuing education and advanced training
for the clinical team. In addition, Vijay will spearhead Assure’s
IONM clinical research projects, act as a Company representative
for industry organizations including ASET, ASNM and ACNS, provide
intermittent technologist case coverage, support business
development efforts and serve as a member of the Clinical
Leadership Team.
Farlinger continued, “Assure’s current and future success is
rooted in the care we have taken to hire, develop, and retain the
best, most dedicated technologists. The demonstrated expertise
Ramesh brings to the organization supports our development plans
and aligns with our principles.”
Farlinger concluded, “In addition, Ramesh will play an important
role on research projects relating to IONM efficacy, safety, cost
savings and improving patient outcomes that we are planning to
launch through our collaboration with the surgeons at the
internationally renowned Texas Back Institute. We envision numerous
ways that this research will help Assure and the IONM industry as a
whole.”
With an emphasis on training, patient care, clinical research
and quality assurance, Mr. Vijay previously served as an
educational leader and IONM technologist at multiple organizations
including Specialty Care. Mr. Vijay has also worked as an
instructor and researcher in higher education at Harvard Medical
School, as an Assistant Professor in the Department of Pediatrics
at the University of Louisville and most recently as an Assistant
Professor in the Department of Pediatrics at the University of
Chicago.
Mr. Vijay earned a Doctorate and Master’s Degree at the Aligarh
Muslim University / All India Institute of Medical Sciences and a
Master and Bachelor of Science from Bangalore University. He also
completed a Postdoctoral Fellowship at the Stanford University
School of Medicine.
Assure’s education and training program, which launched in the
fourth quarter of 2020, will include lectures and classroom work,
laboratory practicums, online instruction and operating room
clinicals. It will also incorporate university internships and
additional educational opportunities past the board certification,
all with the goal of preparing these candidates to pass the CNIM
certification exam and ultimately join Assure’s workforce. The
education program will allow Assure to teach and mold these
technologists as they prepare for a career in IONM and help the
Company maintain rigorous quality control standards and the
clinical excellence that Assure demands for the surgeons it
supports and the patients it serves.
About Assure HoldingsAssure Holdings Corp. is a
Colorado-based company that works with neurosurgeons and orthopedic
spine surgeons to provide a turnkey suite of services that support
intraoperative neuromonitoring activities during invasive
surgeries. Assure employs its own staff of technologists and uses
its own state-of-the-art monitoring equipment, handles 100% of
intraoperative neuromonitoring scheduling and setup, and bills for
all technical services provided. Assure Neuromonitoring is
recognized as providing the highest level of patient care in the
industry and has earned the Joint Commission’s Gold Seal of
Approval®. For more information, visit the company’s website
at www.assureneuromonitoring.com.
Forward-Looking StatementsThis news release may
contain “forward-looking statements” within the meaning of
applicable securities laws, including but not limited to: comments
with respect to the Company’s future growth; future actions of the
Company and the expected effects of certain research projects
relating to IONM. Forward-looking statements may generally be
identified by the use of the words "anticipates," "expects,"
"intends," "plans," "should," "could," "would," "may," "will,"
"believes," "estimates," "potential," "target," or "continue" and
variations or similar expressions. These statements are based upon
the current expectations and beliefs of management and are subject
to certain risks and uncertainties that could cause actual results
to differ materially from those described in the forward-looking
statements. These risks and uncertainties include, but are not
limited to: the Company’s ability to continue to grow; the
enrollment for the Company’s training program; the uncertainty
surrounding the spread of COVID-19 and the impact it will have on
the Company’s operations and economic activity in general; and the
risks and uncertainties discussed in our most recent annual and
quarterly reports filed with the Canadian securities regulators and
available on the Company’s profile on SEDAR at www.sedar.com, which
risks and uncertainties are incorporated herein by reference.
Readers are cautioned not to place undue reliance on
forward-looking statements. Except as required by law, Assure does
not intend, and undertakes no obligation, to update any
forward-looking statements to reflect, in particular, new
information or future events.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
ContactScott Kozak, Investor and Media
RelationsAssure Holdings
Corp.1-720-287-3093Scott.Kozak@assureiom.com
Assure (TSXV:IOM)
Historical Stock Chart
From Sep 2024 to Oct 2024
Assure (TSXV:IOM)
Historical Stock Chart
From Oct 2023 to Oct 2024